Transitioning from clinical research to public health surveillance for new vaccine preventable diseases: the case for rotavirus gastroenteritis

Vaccine
Manju Rani, Sigrun Roesel

Abstract

WHO recommendations for the inclusion of several new vaccines in national immunization programs (NIPs) will require surveillance of additional vaccine preventable diseases (VPDs). To inform vaccine introduction decisions, many global and regional initiatives, including the Asian Rotavirus Surveillance Network (ARSN), have generated disease burden data from multiple countries on these new VPDs. Sentinel hospital-based surveillance, which is both under the overall management of national surveillance agency and as part of a regional network, may be the most practical model for long-term surveillance for common VPDs with a non-specific clinical picture. However integration of these new surveillance strategies with existing VPDs surveillance may face several political, programmatic and technical challenges.

References

Jan 24, 1963·The New England Journal of Medicine·A D LANGMUIR
May 9, 2006·Lancet·David L Heymann, R Bruce Aylward
Feb 19, 2008·Bulletin of the World Health Organization·A DabbaghT Cherian
Apr 29, 2008·Bulletin of the World Health Organization·Rosamund F LewisAddy Kekitiinwa
May 20, 2008·Vaccine·E A S NelsonUNKNOWN Asian Rotavirus Surveillance Network

❮ Previous
Next ❯

Citations

Mar 20, 2009·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Kara GibsonJoel Parlow
Oct 3, 2009·Journal of Gastroenterology and Hepatology·Heather F GiddingMatthew G Law
Apr 27, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Lauren A O'Donnell, Glenn F Rall
Mar 18, 2019·Communicable Diseases Intelligence·UNKNOWN NNDSS Annual Report Working Group
Jun 27, 2015·Epidemiology and Infection·P JainA Jain
Sep 2, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Deborah WilliamsonSally Roberts
May 14, 2018·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Ewelina Gowin, Danuta Januszkiewicz-Lewandowska
Mar 17, 2010·European Journal of Pediatrics·W John PagetUNKNOWN EPIA collaborators
May 10, 2012·Future Microbiology·Katherina Zakikhany, Androulla Efstratiou
May 23, 2013·BMC Public Health·Catherine MacPhailSinead Delany-Moretlwe
Aug 6, 2018·Archives of Virology·María de Los Angeles RibasJudith M Hübschen
Jan 16, 2015·Journal of Clinical Microbiology·Jason W SahlDavid A Rasko
Dec 7, 2019·JMIR Public Health and Surveillance·Khaled Abdullah AlmoayedYousef Khader
Nov 20, 2016·Tropical Medicine & International Health : TM & IH·Halima Boubacar MaïnassaraJudith E Mueller
Dec 12, 2012·Australian and New Zealand Journal of Public Health·Tilman A RuffTerry Nolan
Jun 26, 2015·Open Forum Infectious Diseases·Gaston De SerresAlberto Severini
Nov 6, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Alexis PillsburyUNKNOWN AusVaxSafety, surveillance team

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.